The mandatory hepatitis B vaccine is given to infants at birth for profit alone. It provides no benefit to the infants whom it is administered to. Hepatitis B is as difficult to contract as A.I.D.S. (Acquired Immune Deficiency Syndrome). As with A.I.D.S., the people at risk are drug users and people with multiple sexual partners. It is only transmitted through the following methods:
The vaccine is only effective for 7 years, so by the time the child is in a situation in which he could actually be at risk, the vaccine will no longer be effective. With children who have been born of an infected mother, the children already have the disease; and again, the vaccine is of absolutely no use. In order to help these children, completely safe testing could take place before the pregnant mother gives birth. There are options which can be provided to infected mothers in order to stop the transmission of the disease. Instead, the vaccine is given to infants after it is too late to be useful. Finally, it is unlikely that any of the vaccinated children will shoot-up with illegal drugs before their seventh birthday.
Along with being mercury based, the hepatitis B vaccine is said to be one of the primary causes of neurological problems such as A.D.D. and autism, which points toward its degenerative effects upon the brain. The really unlucky children can die as soon as a day after this vaccination. For most children, the risk of a serious vaccine reaction is approximately 100 times greater than the risk of contracting hepatitis B, and the risks are greater for younger children.
The most serious reported adverse effects from the vaccine seem to be restricted to Caucasians. Despite this, the main long-term safety study was conducted with Alaskan natives to avoid statistical and scientific "complications" (e.g. disturbing facts) and other studies typically involved Asians. These sneaky testing policies are representative of pharmaceutical science.
In 1996, 54 cases of hepatitis B were reported to the C.D.C. (Centers for Disease Control) in the 0-1 age group. Considering that there were 3.9 million births that year, the likelihood of hepatitis B in that age group was 0.001%. In the Vaccine Adverse Event Reporting System (V.A.E.R.S.) there were 1,080 total reports of adverse reactions from hepatitis B vaccinations in the same year and age group. Forty-seven deaths were officially attributed to the vaccine itself.
For every child with hepatitis B, there were 20 reported to have had severe vaccine complications. Bear in mind that only 10% of the reactions are believed to be reported to V.A.E.R.S., so this means that conventional medicine is harming approximately 200 children for every child that it is supposedly protecting from hepatitis B. Even more damning is that these numbers assume that the vaccine is always effective, which it is not.
Only 1.3% of those exposed to hepatitis B will develop a serious complication. Coupled with the low risk of hepatitis infection, its small likelihood of causing serious harm, and the well-documented serious dangers of the vaccine: why are we vaccinating all infants for hepatitis B?
The manufacturers of the hepatitis B vaccine are paid over a billion dollars a year for this vaccine. With that money, they sway opinions. A manufacturer of the vaccine was asked at a 1997 Illinois Board of Health hearing to cite evidence that the vaccine is safe for a one-day-old infant. He replied:
"We have none. Our studies were done on 5 and 10-year-olds."